Table 2.
Demographic and Clinical Characteristics of the Patients
| Characteristic | Low-ACCI (N=32) | High-ACCI (N=32) | Total (N=64) | P-value |
|---|---|---|---|---|
| Age (year) | 88.69±5.86 | 86.50±6.22 | 87.59±6.10 | 0.1527 |
| Gender | 0.1685 | |||
| Male, n (%) | 29 (90.63%) | 25 (78.13%) | 54 (84.38%) | |
| Female, n (%) | 3 (9.37%) | 7 (21.87%) | 10 (15.62%) | |
| ECOG | 0.3087 | |||
| 1–2, n (%) | 21 (65.62%) | 17 (53.13%) | 38 (59.37%) | |
| 3–4, n (%) | 11 (34.38%) | 15 (46.87%) | 26 (40.63%) | |
| Smoking | 0.4513 | |||
| Yes, n (%) | 16 (50.00%) | 13 (40.62%) | 29 (45.31%) | |
| No, n (%) | 16 (50.00%) | 19 (59.38%) | 35 (54.69%) | |
| Hypertension | 0.1306 | |||
| Yes, n (%) | 21 (65.62%) | 15 (46.87%) | 36 (56.25%) | |
| No, n (%) | 11 (34.38%) | 17 (53.13%) | 28 (43.75%) | |
| CHD | 0.2057 | |||
| Yes, n (%) | 21 (65.62%) | 16 (50.00%) | 27 (42.19%) | |
| No, n (%) | 11 (34.38%) | 16 (50.00%) | 37 (57.81%) | |
| Chemotherapy | 0.3135 | |||
| Yes, n (%) | 16 (50.00%) | 20 (62.50%) | 36 (56.25%) | |
| No, n (%) | 16 (50.00%) | 12 (37.05%) | 28 (43.75%) | |
| Radiotherapy | 1.000 | |||
| Yes, n (%) | 6 (18.75%) | 6 (18.75%) | 12 (18.75%) | |
| No, n (%) | 26 (81.25%) | 26 (81.25%) | 52 (81.25%) | |
| Cancer type | 0.3031 | |||
| Gastrointestinal, n (%) | 12 (37.5%) | 17 (53.13%) | 29 (45.31%) | |
| Respiratory, n (%) | 10 (31.25%) | 10 (31.25%) | 20 (31.25%) | |
| Urinary, n (%) | 7 (21.88%) | 2 (6.25%) | 9 (14.06%) | |
| Other, n (%) | 3 (9.37%) | 3 (9.37%) | 6 (9.38%) | |
| CEA (ng/mL) | 9.82±24.60 | 25.08±62.03 | 17.57±47.71 | 0.2041 |
| HbA1c (%) | 6.08±0.96 | 6.77±1.46 | 6.39±1.25 | 0.0589 |
| Hb (g/L) | 117.20±22.48 | 106.70±27.38 | 111.93±25.41 | 0.0981 |
| PLT (*109/L) | 180.10±75.17 | 174.40±68.54 | 177.28±71.41 | 0.7529 |
| Alb (g/L) | 36.14±6.75 | 34.41±4.95 | 35.28±5.94 | 0.2458 |
| Cr (umol/L) | 84.37±36.21 | 103.50±86.53 | 93.92±66.50 | 0.2539 |
Note: Data are expressed as mean ± SD or n (%).
Abbreviations: ACCI, the age-adjusted Charlson comorbidity index; ECOG, Eastern Cooperative Oncology Group Performance Status; CHD, coronary heart disease; CEA, carcino-embryonic antigen; HbA1c, glycosylated hemoglobin type A1c; Hb, hemoglobin; PLT, platelet; Alb, albumin; Cr, creatinine.